Cargando…

Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?

This planet is home to countless species, some more well-known than the others. While we have developed many techniques to be able to interrogate some of the “omics”, proteomics is becoming recognized as a very important part of the puzzle, given how important the protein is as a functional part of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhar, Poshmaal, Samarasinghe, Rasika M., Shigdar, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177290/
https://www.ncbi.nlm.nih.gov/pubmed/32260091
http://dx.doi.org/10.3390/ijms21072485
_version_ 1783525186044166144
author Dhar, Poshmaal
Samarasinghe, Rasika M.
Shigdar, Sarah
author_facet Dhar, Poshmaal
Samarasinghe, Rasika M.
Shigdar, Sarah
author_sort Dhar, Poshmaal
collection PubMed
description This planet is home to countless species, some more well-known than the others. While we have developed many techniques to be able to interrogate some of the “omics”, proteomics is becoming recognized as a very important part of the puzzle, given how important the protein is as a functional part of the cell. Within human health, the proteome is fairly well-established, with numerous reagents being available to decipher cellular pathways. Recent research advancements have assisted in characterizing the proteomes of some model (non-human) species, however, in many other species, we are only just touching the surface. This review considers three main reagent classes—antibodies, aptamers, and nanobodies—as a means of continuing to investigate the proteomes of non-model species without the complications of understanding the full protein signature of a species. Considerations of ease of production, potential applications, and the necessity for producing a new reagent depending on homology are presented.
format Online
Article
Text
id pubmed-7177290
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71772902020-04-28 Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species? Dhar, Poshmaal Samarasinghe, Rasika M. Shigdar, Sarah Int J Mol Sci Review This planet is home to countless species, some more well-known than the others. While we have developed many techniques to be able to interrogate some of the “omics”, proteomics is becoming recognized as a very important part of the puzzle, given how important the protein is as a functional part of the cell. Within human health, the proteome is fairly well-established, with numerous reagents being available to decipher cellular pathways. Recent research advancements have assisted in characterizing the proteomes of some model (non-human) species, however, in many other species, we are only just touching the surface. This review considers three main reagent classes—antibodies, aptamers, and nanobodies—as a means of continuing to investigate the proteomes of non-model species without the complications of understanding the full protein signature of a species. Considerations of ease of production, potential applications, and the necessity for producing a new reagent depending on homology are presented. MDPI 2020-04-03 /pmc/articles/PMC7177290/ /pubmed/32260091 http://dx.doi.org/10.3390/ijms21072485 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dhar, Poshmaal
Samarasinghe, Rasika M.
Shigdar, Sarah
Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
title Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
title_full Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
title_fullStr Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
title_full_unstemmed Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
title_short Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?
title_sort antibodies, nanobodies, or aptamers—which is best for deciphering the proteomes of non-model species?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177290/
https://www.ncbi.nlm.nih.gov/pubmed/32260091
http://dx.doi.org/10.3390/ijms21072485
work_keys_str_mv AT dharposhmaal antibodiesnanobodiesoraptamerswhichisbestfordecipheringtheproteomesofnonmodelspecies
AT samarasingherasikam antibodiesnanobodiesoraptamerswhichisbestfordecipheringtheproteomesofnonmodelspecies
AT shigdarsarah antibodiesnanobodiesoraptamerswhichisbestfordecipheringtheproteomesofnonmodelspecies